BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28594900)

  • 21. Molecular and immunohistochemical analyses of uveal melanoma patient cohort.
    Sarubi HC; Pereira NB; Gomes CC; Gomez RS; Carmo ACM; Melo FM; Bastos-Rodrigues L; Pedrosa MS; Friedman E; De Marco L
    Melanoma Res; 2019 Jun; 29(3):248-253. PubMed ID: 30480620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
    Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
    Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
    Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
    Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic signaling in uveal melanoma.
    Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
    Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.
    Johansson P; Aoude LG; Wadt K; Glasson WJ; Warrier SK; Hewitt AW; Kiilgaard JF; Heegaard S; Isaacs T; Franchina M; Ingvar C; Vermeulen T; Whitehead KJ; Schmidt CW; Palmer JM; Symmons J; Gerdes AM; Jönsson G; Hayward NK
    Oncotarget; 2016 Jan; 7(4):4624-31. PubMed ID: 26683228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for
    Anbunathan H; Verstraten R; Singh AD; Harbour JW; Bowcock AM
    Clin Cancer Res; 2019 Aug; 25(16):5156-5166. PubMed ID: 31227497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in prognostic and predictive testing in uveal melanoma.
    Field MG; Harbour JW
    Curr Opin Ophthalmol; 2014 May; 25(3):234-9. PubMed ID: 24713608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Uveal melanoma, a model disease for splicing alterations and oncogenesis].
    Alsafadi S; Mobuchon L; Rodrigues M; Stern MH
    Med Sci (Paris); 2018 Feb; 34(2):155-160. PubMed ID: 29451486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.
    Drabarek W; Yavuzyigitoglu S; Obulkasim A; van Riet J; Smit KN; van Poppelen NM; Vaarwater J; Brands T; Eussen B; Verdijk RM; Naus NC; Mensink HW; Paridaens D; Boersma E; van de Werken HJG; Kilic E; de Klein A;
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3595-3605. PubMed ID: 31425584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.
    Johansson PA; Brooks K; Newell F; Palmer JM; Wilmott JS; Pritchard AL; Broit N; Wood S; Carlino MS; Leonard C; Koufariotis LT; Nathan V; Beasley AB; Howlie M; Dawson R; Rizos H; Schmidt CW; Long GV; Hamilton H; Kiilgaard JF; Isaacs T; Gray ES; Rolfe OJ; Park JJ; Stark A; Mann GJ; Scolyer RA; Pearson JV; van Baren N; Waddell N; Wadt KW; McGrath LA; Warrier SK; Glasson W; Hayward NK
    Nat Commun; 2020 May; 11(1):2408. PubMed ID: 32415113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.
    Nell RJ; Menger NV; Versluis M; Luyten GPM; Verdijk RM; Madigan MC; Jager MJ; van der Velden PA
    BMC Cancer; 2021 Feb; 21(1):164. PubMed ID: 33588787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.
    van Poppelen NM; de Bruyn DP; Bicer T; Verdijk R; Naus N; Mensink H; Paridaens D; de Klein A; Brosens E; Kiliҫ E
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome sequencing reveals the likely involvement of SOX10 in uveal melanoma.
    Das D; Kaur I; Ali MJ; Biswas NK; Das S; Kumar S; Honavar SG; Maitra A; Chakrabarti S; Majumder PP
    Optom Vis Sci; 2014 Jul; 91(7):e185-92. PubMed ID: 24927141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
    Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
    Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uveal Melanoma:
    Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
    Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-exome sequencing of a meningeal melanocytic tumour reveals activating CYSLTR2 and EIF1AX hotspot mutations and similarities to uveal melanoma.
    Küsters-Vandevelde HVN; Germans MR; Rabbie R; Rashid M; Ten Broek R; Blokx WAM; Prinsen CFM; Adams DJ; Ter Laan M
    Brain Tumor Pathol; 2018 Apr; 35(2):127-130. PubMed ID: 29476293
    [No Abstract]   [Full Text] [Related]  

  • 38. Uveal melanoma: Towards a molecular understanding.
    Smit KN; Jager MJ; de Klein A; Kiliҫ E
    Prog Retin Eye Res; 2020 Mar; 75():100800. PubMed ID: 31563544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Uveal melanoma: current insights into clinical relevance of genetic testing].
    Metz CH; Lohmann D; Zeschnigk M; Bornfeld N
    Klin Monbl Augenheilkd; 2013 Jul; 230(7):686-91. PubMed ID: 23877823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.